Return to content in this issue

Use of concentrated plasma-derived subcutaneous C1 inhibitor as long-term prophylaxis in an 8-year-old child with hereditary angioedema

Lasa EM¹, Herrero L², Martínez S¹, Arruti N¹, Oliver P², Joral A<sup>1

1</sup>Hospital Universitario de Donostia, San Sebastián, Spain
²Hospital de Mendaro, Mendaro, Spain

J Investig Allergol Clin Immunol 2023; Vol. 33(4)
doi: 10.18176/jiaci.0855

• Abstract
• Supplemental Materials

Key words: C inhibitor deficiency, Hereditary angioedema, Children, Long-term treatment, Management

	Title	Type	Size
	doi10.18176_jiaci.0855_supplemental-materials-tables.pdf	pdf	94.18 Kb